Dolutegravir for pregnant women living with HIV

CMAJ. 2020 Mar 2;192(9):E217-E218. doi: 10.1503/cmaj.191227.

¹ Division of Clinical Pharmacology and Toxicology (Zipursky), Department of Medicine, and Institute of Health Policy, Management, and Evaluation (Zipursky), University of Toronto; Women's College Research Institute (Loutfy); Division of Infectious Diseases (Loutfy), Department of Medicine, University of Toronto, Toronto, Ont. jonathan.zipursky@mail.utoronto.ca.
² Division of Clinical Pharmacology and Toxicology (Zipursky), Department of Medicine, and Institute of Health Policy, Management, and Evaluation (Zipursky), University of Toronto; Women's College Research Institute (Loutfy); Division of Infectious Diseases (Loutfy), Department of Medicine, University of Toronto, Toronto, Ont.

No abstract available

MeSH terms